Cubist Systematic Strategies, LLC Bluebird Bio, Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$1.32 - $4.83 $122,857 - $449,547	93,074 New	93,074 $128,000
Q2 2023 Aug 14, 2023	BUY	$2.79 - $5.03 $1.04 Million - $1.88 Million	373,488 New	373,488 $1.23 Million
Q4 2022 Feb 14, 2023	SELL	$5.77 - $8.49 $2.2 Million - $3.24 Million	-381,307 Reduced 84.03%	72,456 $501,000
Q3 2022 Nov 14, 2022	BUY	$3.75 - $7.39 $1.34 Million - $2.65 Million	358,196 Added 374.81%	453,763 $2.87 Million
Q2 2022 Aug 15, 2022	SELL	$2.94 - $5.23 $73,573 - $130,880	-25,025 Reduced 20.75%	95,567 $396,000
Q1 2022 May 16, 2022	BUY	$4.07 - $10.6 $490,809 - $1.28 Million	120,592 New	120,592 $585,000
Q4 2021 Feb 14, 2022	SELL	$8.96 - $16.31 $770,434 - $1.4 Million	-85,986 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$11.24 - $21.0 $750,697 - $1.4 Million	-66,788 Reduced 43.72%	85,986 $1.64 Million
Q2 2021 Aug 16, 2021	SELL	$18.04 - $22.09 $107,356 - $131,457	-5,951 Reduced 3.75%	152,774 $4.89 Million
Q1 2021 May 17, 2021	BUY	$16.59 - $33.89 $712,308 - $1.46 Million	42,936 Added 37.08%	158,725 $4.79 Million
Q4 2020 Feb 16, 2021	BUY	$27.5 - $37.92 $2.42 Million - $3.34 Million	88,153 Added 318.98%	115,789 $5.01 Million
Q3 2020 Nov 16, 2020	BUY	$34.44 - $43.75 $395,612 - $502,556	11,487 Added 71.13%	27,636 $1.49 Million
Q2 2020 Aug 14, 2020	SELL	$27.12 - $45.97 $1.82 Million - $3.09 Million	-67,165 Reduced 80.62%	16,149 $986,000
Q1 2020 May 15, 2020	BUY	$26.16 - $63.5 $1.45 Million - $3.51 Million	55,248 Added 196.85%	83,314 $3.83 Million
Q4 2019 Feb 14, 2020	BUY	$46.96 - $61.67 $428,744 - $563,047	9,130 Added 48.22%	28,066 $2.46 Million
Q3 2019 Nov 14, 2019	SELL	$59.47 - $93.1 $1.48 Million - $2.32 Million	-24,899 Reduced 56.8%	18,936 $1.74 Million
Q2 2019 Aug 14, 2019	BUY	$75.84 - $105.21 $3 Million - $4.16 Million	39,532 Added 918.71%	43,835 $5.58 Million
Q1 2019 May 15, 2019	SELL	$64.44 - $104.11 $258,726 - $418,001	-4,015 Reduced 48.27%	4,303 $677,000
Q4 2018 Feb 14, 2019	BUY	$59.1 - $93.26 $487,988 - $770,047	8,257 Added 13536.07%	8,318 $825,000
Q3 2018 Nov 14, 2018	SELL	$88.86 - $117.49 $2.13 Million - $2.81 Million	-23,939 Reduced 99.75%	61 $9,000
Q2 2018 Aug 14, 2018	BUY	$99.64 - $127.59 $1.16 Million - $1.48 Million	11,628 Added 93.99%	24,000 $3.77 Million
Q1 2018 May 15, 2018	BUY	$105.8 - $150.94 $1.1 Million - $1.57 Million	10,428 Added 536.42%	12,372 $2.11 Million
Q4 2017 Feb 14, 2018	BUY	$81.25 - $130.7 $157,950 - $254,080	1,944	1,944 $346,000

Others Institutions Holding BLUE

# of Institutions

151

Shares Held

63.4M

Call Options Held

264K

Put Options Held

428K

Black Rock Inc. New York, NY

15.4M
Shares

$4.63 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

10.5M
Shares

$3.14 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

4.68M
Shares

$1.4 Million
0.0% of portfolio
Pictet Asset Management Sa Geneva 73, V8

4.67M
Shares

$1.4 Million
0.02% of portfolio
State Street Corp Boston, MA

3.84M
Shares

$1.15 Million
0.0% of portfolio

View Full List

About bluebird bio, Inc.

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $23.1M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

More about BLUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account